Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
FEBS J ; 280(10): 2194-206, 2013 May.
Article in English | MEDLINE | ID: mdl-23331867

ABSTRACT

Vascular endothelial growth factor (VEGF)-stimulated angiogenesis depends on a cross-talk mechanism involving VEGF receptor 2 (VEGFR2), vascular endothelial (VE)-cadherin and the αVß3 integrin. Because we have shown that αVß3 integrin activation is dependent on its incorporation, along with the insulin-like growth factor-1 receptor (IGF1R) kinase, into a ternary receptor complex organized by the matrix receptor syndecan-1 (Sdc1), we questioned the role of this core complex in VEGF-stimulated angiogenesis. We find that the Sdc1-coupled ternary receptor complex is required for VEGF signalling and for stimulation of vascular endothelial cell migration by vascular endothelial cadherin (VE-cadherin) engagement. VE-cadherin binding to Fc/VE-cadherin extracellular domain chimera activates Sdc1-coupled IGF1R and αvß3 integrin; this depends on VEGFR2 and c-Src activated by the cadherin. Blocking homotypic VE-cadherin engagement disrupts VEGF-stimulated cell migration, which is restored by clustering the cadherin in the absence of cell-cell adhesion. This cadherin-dependent stimulation requires VEGFR2 and IGF1R and is blocked by synstatin (SSTN)(92-119), a peptide that competitively disrupts the Sdc1-coupled ternary complex and prevents the αVß3 integrin activation required for VEGFR2 activation. VEGFR2-stimulated angiogenesis in the mouse aortic ring explant assay is disrupted by SSTN, although only early in the process, suggesting that IGF1R coupling to Sdc1 and αVß3 integrin comprises a core activation mechanism activated by VE-cadherin that is necessary for VEGFR2 and integrin activation in the initial stages of endothelial cell dissemination during angiogenesis.


Subject(s)
Antigens, CD/metabolism , Cadherins/metabolism , Endothelial Cells/metabolism , Integrin alphaVbeta3/metabolism , Receptors, Somatomedin/metabolism , Syndecan-1/metabolism , Vascular Endothelial Growth Factor Receptor-2/metabolism , Animals , Antibodies/metabolism , Aorta/drug effects , Aorta/metabolism , Cadherins/antagonists & inhibitors , Cell Adhesion , Cell Movement , Cells, Cultured , Collagen/metabolism , Endothelial Cells/drug effects , Human Umbilical Vein Endothelial Cells , Humans , Mice , Neovascularization, Physiologic/drug effects , Peptides/pharmacology , Phosphorylation , Protein Binding , Protein Interaction Mapping , Receptor Cross-Talk , Receptors, Somatomedin/antagonists & inhibitors , Ternary Complex Factors/metabolism , Vascular Endothelial Growth Factor A/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...